VNRX Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of -862.39% compared to VolitionRX Ltd.'s net margin of --. VolitionRX Ltd.'s return on equity of -- beat Picard Medical's return on equity of --.

VolitionRX Ltd. has a consensus price target of $2.50, signalling upside risk potential of 779.04%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that VolitionRX Ltd. has higher upside potential than Picard Medical, analysts believe VolitionRX Ltd. is more attractive than Picard Medical.

VolitionRX Ltd. has a beta of 1.258, which suggesting that the stock is 25.804% more volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

VolitionRX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. VolitionRX Ltd. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.

VolitionRX Ltd. quarterly revenues are $627.3K, which are larger than Picard Medical quarterly revenues of --. VolitionRX Ltd.'s net income of -$5.4M is higher than Picard Medical's net income of --. Notably, VolitionRX Ltd.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VolitionRX Ltd. is 19.49x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

Retractable Technologies, Inc. has a net margin of -862.39% compared to VolitionRX Ltd.'s net margin of 3.68%. VolitionRX Ltd.'s return on equity of -- beat Retractable Technologies, Inc.'s return on equity of -8.05%.

VolitionRX Ltd. has a consensus price target of $2.50, signalling upside risk potential of 779.04%. On the other hand Retractable Technologies, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that VolitionRX Ltd. has higher upside potential than Retractable Technologies, Inc., analysts believe VolitionRX Ltd. is more attractive than Retractable Technologies, Inc..

VolitionRX Ltd. has a beta of 1.258, which suggesting that the stock is 25.804% more volatile than S&P 500. In comparison Retractable Technologies, Inc. has a beta of 1.133, suggesting its more volatile than the S&P 500 by 13.309%.

VolitionRX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. VolitionRX Ltd. pays -- of its earnings as a dividend. Retractable Technologies, Inc. pays out 1.94% of its earnings as a dividend. Retractable Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

VolitionRX Ltd. quarterly revenues are $627.3K, which are smaller than Retractable Technologies, Inc. quarterly revenues of $10.1M. VolitionRX Ltd.'s net income of -$5.4M is lower than Retractable Technologies, Inc.'s net income of $371K. Notably, VolitionRX Ltd.'s price-to-earnings ratio is -- while Retractable Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VolitionRX Ltd. is 19.49x versus 0.65x for Retractable Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -862.39% compared to VolitionRX Ltd.'s net margin of -1037.17%. VolitionRX Ltd.'s return on equity of -- beat Catheter Precision, Inc.'s return on equity of -192.05%.

VolitionRX Ltd. has a consensus price target of $2.50, signalling upside risk potential of 779.04%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than VolitionRX Ltd., analysts believe Catheter Precision, Inc. is more attractive than VolitionRX Ltd..

VolitionRX Ltd. has a beta of 1.258, which suggesting that the stock is 25.804% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

VolitionRX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. VolitionRX Ltd. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

VolitionRX Ltd. quarterly revenues are $627.3K, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. VolitionRX Ltd.'s net income of -$5.4M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, VolitionRX Ltd.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VolitionRX Ltd. is 19.49x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -862.39% compared to VolitionRX Ltd.'s net margin of 3.93%. VolitionRX Ltd.'s return on equity of -- beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

VolitionRX Ltd. has a consensus price target of $2.50, signalling upside risk potential of 779.04%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 150.92%. Given that VolitionRX Ltd. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe VolitionRX Ltd. is more attractive than Xtant Medical Holdings, Inc..

VolitionRX Ltd. has a beta of 1.258, which suggesting that the stock is 25.804% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

VolitionRX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. VolitionRX Ltd. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

VolitionRX Ltd. quarterly revenues are $627.3K, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. VolitionRX Ltd.'s net income of -$5.4M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, VolitionRX Ltd.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 58.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VolitionRX Ltd. is 19.49x versus 0.65x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.